Form 15-12G - Securities registration termination [Section 12(g)]
February 21 2025 - 7:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE
ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-36576
Marinus Pharmaceuticals, Inc.
(Exact name of registrant as specified in its
charter)
c/o Immedica Pharma AB
Solnavägen 3H, 113 63 Stockholm, Sweden
+46 (0) 8 533 39 500
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
(Title of each class of securities covered by
this Form)
None
(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) |
x |
Rule 12g-4(a)(2) |
¨ |
Rule 12h-3(b)(1)(i) |
x |
Rule 12h-3(b)(1)(ii) |
¨ |
Rule 15d-6 |
¨ |
Approximate number of holders of record as of the certification or
notice date: One (1)
Explanatory
Note: Effective February 11, 2025, Matador Subsidiary, Inc., a Delaware corporation, which is a wholly owned subsidiary
Immedica Pharma AB, a corporation organized and existing under the laws of Sweden, was merged with and into Marinus Pharmaceuticals, Inc.,
a Delaware corporation, with Marinus Pharmaceuticals, Inc. continuing as the surviving corporation and a wholly owned subsidiary
of Immedica Pharma AB.
Pursuant to the requirements of the Securities Exchange Act of
1934, Marinus Pharmaceuticals, Inc., has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
|
Marinus Pharmaceuticals, Inc. |
|
|
|
Date: February 21, 2025 |
By: |
/s/ Anders Edvell |
|
|
Anders
Edvell |
|
|
Chief
Executive Officer |
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
From Feb 2024 to Feb 2025